Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2009 2
2010 3
2011 2
2012 1
2013 3
2014 3
2015 7
2016 5
2017 4
2018 3
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Genome Editing: Past, Present, and Future.
Carroll D. Carroll D. Yale J Biol Med. 2017 Dec 19;90(4):653-659. eCollection 2017 Dec. Yale J Biol Med. 2017. PMID: 29259529 Free PMC article. Review.
Genome engineering with zinc-finger nucleases.
Carroll D. Carroll D. Genetics. 2011 Aug;188(4):773-82. doi: 10.1534/genetics.111.131433. Genetics. 2011. PMID: 21828278 Free PMC article. Review.
Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA, Corn JE, Carroll D. DeWitt MA, et al. Methods. 2017 May 15;121-122:9-15. doi: 10.1016/j.ymeth.2017.04.003. Epub 2017 Apr 12. Methods. 2017. PMID: 28410976 Free PMC article.
Origins of Programmable Nucleases for Genome Engineering.
Chandrasegaran S, Carroll D. Chandrasegaran S, et al. J Mol Biol. 2016 Feb 27;428(5 Pt B):963-89. doi: 10.1016/j.jmb.2015.10.014. Epub 2015 Oct 23. J Mol Biol. 2016. PMID: 26506267 Free PMC article. Review.
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells.
DeWitt MA, Magis W, Bray NL, Wang T, Berman JR, Urbinati F, Heo SJ, Mitros T, Muñoz DP, Boffelli D, Kohn DB, Walters MC, Carroll D, Martin DI, Corn JE. DeWitt MA, et al. Sci Transl Med. 2016 Oct 12;8(360):360ra134. doi: 10.1126/scitranslmed.aaf9336. Sci Transl Med. 2016. PMID: 27733558 Free PMC article.
Genome engineering with targetable nucleases.
Carroll D. Carroll D. Annu Rev Biochem. 2014;83:409-39. doi: 10.1146/annurev-biochem-060713-035418. Epub 2014 Mar 3. Annu Rev Biochem. 2014. PMID: 24606144 Review.
p53 Throws CRISPR a Curve.
Carroll D. Carroll D. Trends Pharmacol Sci. 2018 Sep;39(9):783-784. doi: 10.1016/j.tips.2018.06.005. Epub 2018 Jul 11. Trends Pharmacol Sci. 2018. PMID: 30006230
CRISPR germline engineering--the community speaks.
Bosley KS, Botchan M, Bredenoord AL, Carroll D, Charo RA, Charpentier E, Cohen R, Corn J, Doudna J, Feng G, Greely HT, Isasi R, Ji W, Kim JS, Knoppers B, Lanphier E, Li J, Lovell-Badge R, Martin GS, Moreno J, Naldini L, Pera M, Perry AC, Venter JC, Zhang F, Zhou Q. Bosley KS, et al. Nat Biotechnol. 2015 May;33(5):478-86. doi: 10.1038/nbt.3227. Nat Biotechnol. 2015. PMID: 25965754 No abstract available.
Biotechnology. A prudent path forward for genomic engineering and germline gene modification.
Baltimore D, Berg P, Botchan M, Carroll D, Charo RA, Church G, Corn JE, Daley GQ, Doudna JA, Fenner M, Greely HT, Jinek M, Martin GS, Penhoet E, Puck J, Sternberg SH, Weissman JS, Yamamoto KR. Baltimore D, et al. Science. 2015 Apr 3;348(6230):36-8. doi: 10.1126/science.aab1028. Epub 2015 Mar 19. Science. 2015. PMID: 25791083 Free PMC article.
Genome editing of human embryos: to edit or not to edit, that is the question.
Chandrasegaran S, Bullen CK, Carroll D. Chandrasegaran S, et al. J Clin Invest. 2017 Oct 2;127(10):3588-3590. doi: 10.1172/JCI96962. Epub 2017 Aug 28. J Clin Invest. 2017. PMID: 28846073 Free PMC article. No abstract available.
36 results
Jump to page
Feedback